SF - Stifel Financial Corp
Canada Pension Plan Investment Board purchased a new position in Stifel Financial Corporation (NYSE: SF) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 93,950 shares of the financial services provider's stock, valued at approximately $6,555,000. Canada Pension Plan Investment Board
ST. LOUIS, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for July 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.
Stifel has reiterated its 'buy' rating on Faron Pharmaceuticals Limited (AIM:FARN), the Finnish biotech, maintaining a price target of €2.50 after the company's interims, which showed the company well-funded to push on with value-accretive work in the clinic. The stock closed at €0.48 on 25 August, implying upside of 418.1% to the target price.
Bank of New York Mellon Corp acquired a new stake in Stifel Financial Corporation (NYSE: SF) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,336,318 shares of the financial services provider's stock, valued at approximately $93,235,000. Bank of New York Mellon Corp
Bank of Nova Scotia acquired a new stake in Stifel Financial Corporation (NYSE: SF) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 519,811 shares of the financial services provider's stock, valued at approximately $36,267,000. Bank of Nova Scotia owned 0.34%
BlackRock Inc. purchased a new position in shares of Stifel Financial Corporation (NYSE: SF) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,779,953 shares of the financial services provider's stock, valued at approximately $1,031,197,000. BlackRock Inc. owned about 9.63% of Stifel Financial
Algebris UK Ltd. bought a new position in shares of Stifel Financial Corporation (NYSE: SF) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,007,696 shares of the financial services provider's stock, valued at approximately $70,086,000. Stifel Financial comprises
Empowered Funds LLC lifted its holdings in shares of Stifel Financial Corporation (NYSE: SF) by 646.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,630 shares of the financial services provider's stock after purchasing an additional
Cetera Investment Advisers boosted its holdings in shares of Stifel Financial Corporation (NYSE: SF) by 54.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,671 shares of the financial services provider's stock after buying an additional 12,237 shares during the
ST. LOUIS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.34 per share, payable September 15, 2026, to shareholders of record at the close of business on September 1, 2026.
/PRNewswire/ -- 1919 Investment Counsel, LLC ("1919"), a subsidiary of Stifel Financial Corp. ("Stifel"), is proud to announce its recognition as one of
Assetmark Inc. increased its holdings in shares of Stifel Financial Corporation (NYSE: SF) by 35.7% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 35,780 shares of the financial services provider's stock after purchasing an additional 9,413 shares during the period. Assetmark Inc.'s holdings in Stifel
Custom Health Holdings Inc (TSX:CHLT) just landed Buy-rated coverage from Stifel, with analysts setting a C$12 price target and pointing to upside as high as C$18 a share. The pitch: a pill-dispensing platform that's quietly solving one of healthcare's most expensive headaches.
Ron Kruszewski, Stifel chairman and ceo, says artificial intelligence will lead to productivity gains. He says financial advisers are still valuable and AI can help them.
Stifel Financial Corp. (SF) Q2 2026 Earnings Call Transcript
Stifel Financial NYSE: SF reported what executives described as the strongest first half in the company's history, with second-quarter revenue and earnings rising from a year earlier as wealth management, investment banking and net interest income all contributed to growth.
Stifel Financial remains a "Buy" despite recent underperformance, with AI-driven cash sweep fears seen as overdone and not reflected in current results. Q2 earnings beat expectations, with revenue up 11% to $1.45 billion and client assets rising 12% to $580 billion, supporting robust wealth management and investment banking momentum. Net interest income, a key profit driver, remains resilient; cash balances are stable, and Fed rate hikes could further benefit SF's earnings.
Stifel Financial (SF) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.14 per share a year ago.
ST. LOUIS, July 22, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.45 billion for the three months ended June 30, 2026, compared with $1.28 billion a year ago. Net income available to common shareholders was $217.2 million, or $1.34 per diluted common share, compared with $145.7 million, or $0.89 per diluted common share (1) for the second quarter of 2025.
STAMFORD, Conn., July 20, 2026 (GLOBE NEWSWIRE) -- Eaton Partners, one of the largest private capital advisory firms and a wholly-owned subsidiary of Stifel Financial Corp. (NYSE: SF), is announcing key appointments to expand its Private Capital Advisory (“PCA”) group, including the addition of Mickey Brunton as Managing Director and Co-Head of GP-led Secondaries.